ResMed Inc. (1RMD)
MTA
198.90
-0.95 (-0.48%)
Closed
Aug 24, 2026
Day's Range
198.40198.90
52 wk Range
157.60243.20
Financial Statements - 1RMD - ResMed Inc.
Revenue
5.14B▲ 9.8%
Net Income
1.40B▲ 37.2%Net Margin 27.2%
EBITDA
1.92B▲ 21.0%
Free Cash Flow
1.65B▲ 28.3%
Income Statement
| Period Ending | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Sales | 5.14B | 4.68B |
| Cost of Goods | 2.09B | 2.02B |
| Gross Profit | 3.05B | 2.65B |
 Operating Expense | - | - |
| Operating Income | 1.68B | 1.38B |
| Non-Operating Interest | - | - |
| Other Income Expense | -13.94M | -73.61M |
| Pre Tax Income | 1.67B | 1.26B |
| Income Tax | 276.84M | 243.84M |
| Net Income | 1.40B | 1.02B |
| EPS Basic | 9.55 | - |
| EPS Diluted | 9.51 | - |
| Basic Shares Outstanding | 146.71M | - |
| Diluted Shares Outstanding | 146.71M | - |
| Ebit | 1.68B | 1.31B |
| Ebitda | 1.92B | 1.59B |
| Net Income Continuous Operations | 1.40B | 1.02B |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
